PET Positive
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy (NCT06096870) | National Cancer Institute (NCI) | 2024-04-22 |
Track PET Positive automatically
Every clearance here is in the API, with alerts when new ones post.